Clinical Trial Update: CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating adding CA-4948 to standard chemotherapy for metastatic or unresectable pancreatic cancer and the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• CA-4948

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8 | Phase 1 | Status: RECRUITING